Production of highly pure human glycosylated GDNF in a mammalian cell line

International Journal of Pharmaceutics

Volumn 385, Issue 1-2, 2010, Pages 6-11

  Ansorena, Eduardo ^a   Garbayo, Elisa ^a   Lanciego, José L ^b   Aymerich, María S ^b   Blanco Prieto, María J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

GDNF; Glycosylated proteins; Neurotrophic factors; Parkinson's disease; Purification of proteins; Therapeutic proteins

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOSYLATED PROTEIN; NEUROTROPHIC FACTOR; RECOMBINANT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOASSAY; CELL LINE; CONTROLLED STUDY; DRUG DEPENDENCE; EYE DISEASE; GEL FILTRATION; HUMAN; HUMAN CELL; IN VIVO STUDY; ION EXCHANGE CHROMATOGRAPHY; MAMMAL CELL; NERVE REGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SPINAL CORD INJURY;

ANIMALS; BIOLOGICAL ASSAY; BIOTECHNOLOGY; CATION EXCHANGE RESINS; CELL DIFFERENTIATION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; FIBROBLASTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLYCOSYLATION; HUMANS; NEURONS; PC12 CELLS; PHENOTYPE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TRANSDUCTION, GENETIC;

EID: 72149124204     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.10.015     Document Type: Article

References (56)

1. Arenas E., Trupp M., Akerud P., and Ibanez C.F. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15 (1995) 1465-1473
2. Barras F.M., Pasche P., Bouche N., Aebischer P., and Zurn A.D. Glial cell line-derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat. J. Neurosci. Res. 70 (2002) 746-755
3. Bennett D.L., Michael G.J., Ramachandran N., Munson J.B., Averill S., Yan Q., Mcmahon S.B., and Priestley J.V. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J. Neurosci. 18 (1998) 3059-3072
4. Blesch A., and Tuszynski M.H. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J. Comp. Neurol. 467 (2003) 403-417
5. Buch P.K., Maclaren R.E., Duran Y., Balaggan K.S., Macneil A., Schlichtenbrede F.C., Smith A.J., and Ali R.R. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration. Mol. Ther. 14 (2006) 700-709
6. Cao X., and Schoichet M.S. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 20 (1999) 329-339
7. Carnicella S., and Ron D. GDNF, a potential target to treat addiction. Pharmacol. Ther. 122 (2009) 9-18
8. Ciriza J., Moreno-igoa M., Calvo A.C., Yague G., Palacio J., Miana-Mena F.J., Munoz M.J., Zaragoza P., Brulet P., and Osta R. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model. Restor. Neurol. Neurosci. 26 (2008) 459-465
9. Chen Z.Y., Chai Y.F., Cao L., Lu C.L., and He C. Glial cell line-derived neurotrophic factor enhances axonal regeneration following sciatic nerve transection in adult rats. Brain Res. 902 (2001) 272-276
10. Chen Z.Y., He Z.Y., He C., Lu C.L., and Wu X.F. Human glial cell-line-derived neurotrophic factor: a structure-function analysis. Biochem. Biophys. Res. Commun. 268 (2000) 692-696
11. Chen Z.Y., Huang A.J., He C., Lu C.L., and Wu X.F. Expression of human GDNF in methyltrophic yeast Pichia pastoris and silkworm larvae. Sheng. Wu Gong Cheng Xue Bao 16 (2000) 561-565
12. Chen Z.Y., Sun J.X., Li J.H., He C., Lu C.L., and Wu X.F. Preparation of recombinant human GDNF by baculovirus expression system and analysis of its biological activities. Biochem. Biophys. Res. Commun. 273 (2000) 902-906
13. Cheng H., Wu J.P., and Tzeng S.F. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. J. Neurosci. Res. 69 (2002) 397-405
14. Chu L., and Robinson D.K. Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol. 12 (2001) 180-187
15. Garbayo E., Ansorena E., Lanciego J.L., Aymerich M.S., and Blanco-Prieto M.J. Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor. Int. J. Pharm. 344 (2007) 9-15
16. Gerngross T.U. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol. 22 (2004) 1409-1414
17. Giehl K.M., Schutte A., Mestres P., and Yan Q. The survival-promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism. J. Neurosci. 18 (1998) 7351-7360
18. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., and Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9 (2003) 589-595
19. Gribben J.G., Devereux S., Thomas N.S., Keim M., Jones H.M., Goldstone A.H., and Linch D.C. Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF. Lancet 335 (1990) 434-437
20. Guzen F.P., De Almeida Leme R.J., De Andrade M.S., De Luca B.A., and Chadi G. Glial cell line-derived neurotrophic factor added to a sciatic nerve fragment grafted in a spinal cord gap ameliorates motor impairments in rats and increases local axonal growth. Restor. Neurol. Neurosci. 27 (2009) 1-16
21. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., and Simpson L.C. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266 (1994) 1062-1064
22. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., and Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182 (1994) 107-111
23. Hottinger A.F., Azzouz M., Deglon N., Aebischer P., and Zurn A.D. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J. Neurosci. 20 (2000) 5587-5593
24. Jana S., and Deb J.K. Strategies for efficient production of heterologous proteins in Escherichia coli. Appl. Microbiol. Biotechnol. 67 (2005) 289-298
25. Jarvis D.L., Kawar Z.S., and Hollister J.R. Engineering N-glycosylation pathways in the baculovirus-insect cell system. Curr. Opin. Biotechnol. 9 (1998) 528-533
26. Jiang C., Moore M.J., Zhang X., Klassen H., Langer R., and Young M. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Mol. Vis. 13 (2007) 1783-1792
27. Karpusas M., Whitty A., Runkel L., and Hochman P. The structure of human interferon-beta: implications for activity. Cell. Mol. Life Sci. 54 (1998) 1203-1216
28. Klocker N., Braunling F., Isenmann S., and Bahr M. In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells. Neuroreport 8 (1997) 3439-3442
29. Lang A.E., Gill S., Patel N.K., Lozano A., Nutt J.G., Penn R., Brooks D.J., Hotton G., Moro E., Heywood P., Brodsky M.A., Burchiel K., Kelly P., Dalvi A., Scott B., Stacy M., Turner D., Wooten V.G., Elias W.J., Laws E.R., Dhawan V., Stoessl A.J., Matcham J., Coffey R.J., and Traub M. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59 (2006) 459-466
30. Lee S.B., Park J.S., Lee S., Park J., Yu S., Kim H., Kim D., Byun T.H., Baek K., Ahn Y.J., and Yoon J. Overproduction of recombinant human VEGF (vascular endothelial growth factor) in Chinese hamster ovary cells. J. Microbiol. Biotechnol. 18 (2008) 183-187
31. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., and Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
32. Lin L.F., Zhang T.J., Collins F., and Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63 (1994) 758-768
33. März L., Altmann F., Staudacher E., and Kubelka V. Protein glycosylation in insects. In: Montreuil J., Vliegenthart J.F.G., and Schachter H. (Eds). Glycoproteins (1995), Elsevier, Amsterdam
34. Mohajeri M.H., Figlewicz D.A., and Bohn M.C. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther. 10 (1999) 1853-1866
35. Molliver D.C., Wright D.E., Leitner M.L., Parsadanian A.S., Doster K., Wen D., Yan Q., and Snider W.D. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron 19 (1997) 849-861
36. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.F., Li L., Lo A.C., Newsome A.L., Prevette D.M., and Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373 (1995) 344-346
37. Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., and Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol. 57 (2005) 298-302
38. Piquilloud G., Christen T., Pfister L.A., Gander B., and Papaloizos M.Y. Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs. Eur. J. Neurosci. 26 (2007) 1109-1117
39. Sajadi A., Bensadoun J.C., Schneider B.L., Lo Bianco C., and Aebischer P. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. Neurobiol. Dis. 22 (2006) 119-129
40. Schellekens H. Bioequivalence and the immunogenicity of biopharmaceuticals. Nat. Rev. Drug Discov. 1 (2002) 457-462
41. Schmeer C., Straten G., Kugler S., Gravel C., Bahr M., and Isenmann S. Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of glial cell-line derived neurotrophic factor in vivo. Eur. J. Neurosci. 15 (2002) 637-643
42. Sharma H.S. Post-traumatic application of brain-derived neurotrophic factor and glia-derived neurotrophic factor on the rat spinal cord enhances neuroprotection and improves motor function. Acta Neurochir. Suppl. 96 (2006) 329-334
43. Shi Y., Zhou L., Tian J., and Wang Y. Transplantation of neural stem cells overexpressing glia-derived neurotrophic factor promotes facial nerve regeneration. Acta Otolaryngol. (2008) 1-9
44. Slevin J.T., Gash D.M., Smith C.D., Gerhardt G.A., Kryscio R., Chebrolu H., Walton A., Wagner R., and Young A.B. Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. J. Neurosurg. 106 (2007) 614-620
45. Slevin J.T., Gerhardt G.A., Smith C.D., Gash D.M., Kryscio R., and Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102 (2005) 216-222
46. Suzuki M., Mchugh J., Tork C., Shelley B., Hayes A., Bellantuono I., Aebischer P., and Svendsen C.N. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol. Ther. 16 (2008) 2002-2010
47. Swartz J.R. Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 12 (2001) 195-201
48. Tatarewicz S.M., Wei X., Gupta S., Masterman D., Swanson S.J., and Moxness M.S. Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion. J. Clin. Immunol. 27 (2007) 620-627
49. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J. Anat. 194 (1999) 1-14
50. Trupp M., Ryden M., Jornvall H., Funakoshi H., Timmusk T., Arenas E., and Ibanez C.F. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130 (1995) 137-148
51. Wang Y., Lin S.Z., Chiou A.L., Williams L.R., and Hoffer B.J. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17 (1997) 4341-4348
52. Ward M.S., Khoobehi A., Lavik E.B., Langer R., and Young M.J. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J. Pharm. Sci. 96 (2007) 558-568
53. Wildt S., and Gerngross T.U. The humanization of N-glycosylation pathways in yeast. Nat. Rev. Microbiol. 3 (2005) 119-128
54. Wood M.D., Moore A.M., Hunter D.A., Tuffaha S., Borschel G.H., Mackinnon S.E., and Sakiyama-Elbert S.E. Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater. 5 (2009) 959-968
55. Wu W.C., Lai C.C., Chen S.L., Sun M.H., Xiao X., Chen T.L., Tsai R.J., Kuo S.W., and Tsao Y.P. GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol. Vis. 10 (2004) 93-102
56. Yan Q., Wang J., Matheson C.R., and Urich J.L. Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF). J. Neurobiol. 38 (1999) 382-390